Literature DB >> 6508975

Do gastric contents modify antidotal efficacy of oral activated charcoal?

K T Olkkola, P J Neuvonen.   

Abstract

The effect of food on the antidotal efficacy of activated charcoal was studied in six healthy volunteers, who ingested aspirin 1000 mg, mexiletine 200 mg and tolfenamic acid 400 mg in a randomized cross-over study. Activated charcoal 25 g, suspended in water, was administered 5 min or 60 min after the drugs were taken on an empty stomach or after a standard meal. The serum concentrations and the cumulative excretion into urine of the drugs were followed for 48 h. When the drugs were taken on an empty stomach, activated charcoal given 5 min or 60 min afterwards reduced the bioavailability of the drugs by 75-98% or 10-60%, respectively. Food moderately weakened the effect of activated charcoal administered 5 min after the drugs, but when the charcoal was given 1 h later the effect was still practically the same, the reduction of absorption varying in both cases in the range of 45-85%. Thus the efficacy of charcoal given 60 min after the drugs was better after a standard meal than on an empty stomach. Presence of food in the stomach of patients with drug overdosage modifies the efficacy of activated charcoal and gives it more time to adsorb drugs in the gastrointestinal canal, possibly by slowing gastric emptying rate.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6508975      PMCID: PMC1463541          DOI: 10.1111/j.1365-2125.1984.tb02527.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  A simple fluorometric procedure for determining salicylic acid in biologic tissues.

Authors:  M A CHIRIGOS; S UDENFRIEND
Journal:  J Lab Clin Med       Date:  1959-11

2.  Bioavailability of D-propoxyphene, acetyl salicylic acid, and phenazone in a combination tablet (Doleron): interindividual variation and influence of food intake.

Authors:  A Melander; A Berlin-Wahlén; N O Bodin; K Danielson; B Gustafsson; S Lindgren; D Westerlund
Journal:  Acta Med Scand       Date:  1977

Review 3.  Use of activated charcoal in acute poisoning.

Authors:  J W Hayden; E G Comstock
Journal:  Clin Toxicol       Date:  1975       Impact factor: 4.467

4.  Comparison of charcoal and attapulgite as gastrointestinal sequestrants in acute drug ingestions.

Authors:  J P Atkinson; D L Azarnoff
Journal:  Clin Toxicol       Date:  1971-03       Impact factor: 4.467

5.  Effect of activated charcoal on aspirin absorption in man. Part I.

Authors:  G Levy; T Tsuchiya
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

6.  Mefenamic acid overdosage.

Authors:  M Balali-Mood; J A Critchley; A T Proudfoot; L F Prescott
Journal:  Lancet       Date:  1981-06-20       Impact factor: 79.321

7.  Human pharmacokinetics of tolfenamic acid, a new anti-inflammatory agent.

Authors:  P J Pentikäinen; P J Neuvonen; C Backman
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

8.  Letter: Fatal mexiletine overdose.

Authors:  P Jequier; R Jones; A Mackintosh
Journal:  Lancet       Date:  1976-02-21       Impact factor: 79.321

9.  Simultaneous plasma levels determination of mexiletine and one of its metabolites by electron capture gas-liquid chromatography.

Authors:  A Pachecus; Y Santoni; M Fornaris; S Magnan; C Aubert; A Ragon; J P Cano
Journal:  Arzneimittelforschung       Date:  1982

10.  Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man.

Authors:  P J Neuvonen; S M Elfving; E Elonen
Journal:  Eur J Clin Pharmacol       Date:  1978-05-31       Impact factor: 2.953

View more
  10 in total

1.  Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males.

Authors:  H Stass; D Kubitza; J-G Möller; H Delesen
Journal:  Br J Clin Pharmacol       Date:  2005-05       Impact factor: 4.335

Review 2.  Toxic effects of nonsteroidal anti-inflammatory drugs in overdose. An overview of recent evidence on clinical effects and dose-response relationships.

Authors:  S C Smolinske; A H Hall; S A Vandenberg; D G Spoerke; P V McBride
Journal:  Drug Saf       Date:  1990 Jul-Aug       Impact factor: 5.606

3.  Role of repeated oral doses of activated charcoal in clinical toxicology.

Authors:  S M Pond
Journal:  Med Toxicol       Date:  1986 Jan-Feb

4.  How useful is activated charcoal?

Authors:  J A Vale; A T Proudfoot
Journal:  BMJ       Date:  1993-01-09

Review 5.  Clinical toxicology.

Authors:  J A Vale
Journal:  Postgrad Med J       Date:  1993-01       Impact factor: 2.401

6.  Effectiveness of delayed activated charcoal administration in simulated paracetamol (acetaminophen) overdose.

Authors:  P J Yeates; S H Thomas
Journal:  Br J Clin Pharmacol       Date:  2000-01       Impact factor: 4.335

Review 7.  Acute poisoning due to non-steroidal anti-inflammatory drugs. Clinical features and management.

Authors:  J A Vale; T J Meredith
Journal:  Med Toxicol       Date:  1986 Jan-Feb

Review 8.  Non-narcotic analgesics. Problems of overdosage.

Authors:  T J Meredith; J A Vale
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 9.  Oral activated charcoal in the treatment of intoxications. Role of single and repeated doses.

Authors:  P J Neuvonen; K T Olkkola
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jan-Dec

10.  Effect of food on systemic exposure to niflumic acid following postprandial administration of talniflumate.

Authors:  Wonku Kang; Kibum Kim; Eun-Young Kim; Kwang-il Kwon; Jun Seok Bang; Young-Ran Yoon
Journal:  Eur J Clin Pharmacol       Date:  2008-07-08       Impact factor: 2.953

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.